A new Alzheimer's drug called donanemab could be available on the NHS by 2025, the i reports, hailing it as a "breakthrough".
Researchers have found that treatment appears to slow the pace of the disease by a third, but there are some potential side effects - including brain swelling, the paper notes.
Like Leqembi and Aduhelm, donanemab is a monoclonal antibody that attacks plaque in the brain, which is made up of a protein called amyloid.
Amyloid plaques lead to the spread of another protein called tau. Both amyloid and tau proteins lead to the development of Alzheimer’s disease.
Prince Nikolaos de Grece and Chrysi Vardinoyannis have officially announced their engagement, with a wedding…
A Greek woman was arrested by the occupying authorities in Cyprus after attempting to smuggle…
Mimis Domazos, one of Greece's greatest football legends, has passed away at the age of…
Two gynecologists accused of involvement in an illegal adoption ring in Chania have been released…
The monks stated that the persecution of the Ukrainian Orthodox Church continues with unrelenting intensity.…
Energean, a British-Greek oil and gas company, announced on Thursday that it has finalized a…